Defining the Triple Negative Breast Cancer Morpholome

Share this post on:


This webinar will be hosted live and available on-demand

Thursday, March 21, 2024
12:00 -1:00 PM Eastern Time 

The understanding of triple-negative breast cancer (TNBC) metastasis remains limited despite extensive genomic studies. Morphological analysis can guide molecular and sequencing-based profiling of metastatic TNBC, helping scientists detect functional metastatic states missed by current genomic strategies. Researchers at MD Anderson Cancer Center use quantitative imaging assays to examine the cellular morpholome in metastatic TNBC tissues and develop new detection, diagnostic, and treatment strategies.

In this webinar brought to you by Deepcell, Andres Nevarez will define the TNBC morpholome and discuss morphological insights into TNBC progression and metastasis.

Topics to be covered 

  • Cancer cell morphology across genomically distinct clonal TNBC cell lines
  • How quantitative imaging reveals the morpholome of metastatic TNBC
  • Sequencing-based morpholomic profiling that exposes hidden drivers of metastasis
Andres Nevarez, PhD 

Andres Nevarez, PhD 
Postdoctoral Fellow
MD Anderson Cancer Center
University of Texas

Sponsored by

Share this post on:

Leave a Reply

Your email address will not be published. Required fields are marked *